PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers identify new pathway, enhancing tamoxifen to tame aggressive breast cancer

2013-04-23
(Press-News.org) Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer. The research, published in the journal EMBO Molecular Medicine, is a promising development for women with basal-like breast cancer, sometimes known as triple-negative disease. This subtype has a poor prognosis because it is notoriously resistant to treatment. In fact, basal-like cancers lack the three most common breast cancer biomarkers – the estrogen receptor, the progesterone receptor, and theHer2/neu receptor – and without these receptors, the usual front-line treatments are not effective. Until recently, tamoxifen was known primarily for its ability to block estrogen receptors on the outside of cancer cells. However, new studies have suggested that when tamoxifen is given in higher doses, it works through a second mechanism of action independent of the estrogen receptor. This second mechanism was the focus of the Rochester laboratory. Led by doctoral student Hsing-Yu Chen and Mark Noble, Ph.D., professor of Biomedical Genetics at URMC, the team studied the molecular mechanism that allows basal-like breast cancer cells to escape the secondary effects of tamoxifen, and discovered that two proteins are critical in this escape. One protein, called c-Cbl, controls the levels of multiple receptors that are critical for cancer cell function. A second protein, Cdc42, can inhibit c-Cbl and is responsible for the tumor's underlying resistance. The team also discovered that targeting Cdc42 – and thus inhibiting the inhibitor - with an experimental drug compound known as ML141 restored c-Cbl's normal function. Through additional work in animal models and in human cell cultures, the team demonstrated that when ML141 is paired with tamoxifen, it enhances the ability of tamoxifen to induce cancer cell death and suppress the growth of new cancer cells. Neither drug alone had the same effect on basal-like breast cells. Noble believes there is considerable value to targeting Cdc42, because elevated levels of the protein have been observed in multiple types of cancer. (In this context, scientists are also studying the potential for tamoxifen as a therapy for other cancers.) The powerful ML141-tamoxifen drug combination looks like it has two more important features: It selectively targets cancer cells while sparing normal, healthy cells; and it appears to cripple cancer stem cells, the primitive cells responsible for initiating new tumors and for fueling the bulk of the tumor cell population. "Our work is very exciting because our approach simultaneously addresses two of the most critical challenges in cancer research -- to increase the utility of existing therapies and to discover new vulnerabilities of cancer cells," said Noble, who also is a leader at UR's Stem Cell and Regenerative Medicine Institute. "Based on these discoveries, we are already pushing forward with new compounds and with new approaches that might make clinical translation of this discovery much more rapid than would occur with traditional drug-discovery approaches." ### The National Institutes of Health, Susan G. Komen for the Cure, the U.S. Department of Defense, and the New York State NYSTEM initiative funded the research. Co-authors include Yin Miranda Yang, Ph.D., and Brett Stevens, Ph.D. Hsing-Yu Chen won a Howard Hughes Medical Institute Award of Excellence in 2012 for a poster presentation on this topic. Journal citation: Chen H-Y, Yang YM, Stevens BM, Noble M (2013) Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. EMBO Mol Med, DOI: 10.1002/emmm.201202140 END


ELSE PRESS RELEASES FROM THIS DATE:

Infants' sweat response predicts aggressive behavior as toddlers

2013-04-23
Infants who sweat less in response to scary situations at age 1 show more physical and verbal aggression at age 3, according to new research published in Psychological Science, a journal of the Association for Psychological Science. Lower levels of sweat, as measured by skin conductance activity (SCA), have been linked with conduct disorder and aggressive behavior in children and adolescents. Researchers hypothesize that aggressive children may not experience as strong of an emotional response to fearful situations as their less aggressive peers do; because they have ...

Doctors-in-training spend very little time at patient bedside, study finds

2013-04-23
Medical interns spend just 12 percent of their time examining and talking with patients, and more than 40 percent of their time behind a computer, according to a new Johns Hopkins study that closely followed first-year residents at Baltimore's two large academic medical centers. Indeed, the study found, interns spent nearly as much time walking (7 percent) as they did caring for patients at the bedside. Compared with similar time-tracking studies done before 2003, when hospitals were first required to limit the number of consecutive working hours for trainees, the researchers ...

What drives activity on Pinterest?

2013-04-23
Researchers at Georgia Tech and the University of Minnesota have released a new study that uses statistical data to help understand the motivations behind Pinterest activity, the roles gender plays among users and the factors that distinguish Pinterest from other popular social networking sites. Led by Assistant Professor Eric Gilbert of Georgia Tech's School of Interactive Computing, working in collaboration with Professor Loren Terveen from the University of Minnesota's College of Science and Engineering, the study reveals findings that could have implications for both ...

Vitamin E identified as potential weapon against obesity

2013-04-23
BOSTON — A potential new way to fight obesity-related illness has been uncovered, thanks to serendipitous research led by investigators at the Case Western Reserve University School of Medicine. The collaborators, from Case Western Reserve University, the Cleveland Clinic Foundation and Cornell University, discovered the essential nutrient vitamin E can alleviate symptoms of liver disease brought on by obesity. "The implications of our findings could have a direct impact on the lives of the approximately 63 million Americans who are at potential risk for developing obesity-related ...

AGU: Wildfires can burn hot without ruining soil, new study finds

2013-04-23
WASHINGTON - When scientists torched an entire 22-acre watershed in Portugal in a recent experiment, their research yielded a counterintuitive result: Large, hot fires do not necessarily beget hot, scorched soil. It's well known that wildfires can leave surface soil burned and barren, which increases the risk of erosion and hinders a landscape's ability to recover. But the scientists' fiery test found that the hotter the fire-and the denser the vegetation feeding the flames-the less the underlying soil heated up, an inverse effect which runs contrary to previous ...

Saint Louis University, University of Toronto biologists help decode turtle genome

2013-04-23
ST. LOUIS – A group of 50 researchers from around the globe, including biology professors Daniel Warren, Ph.D., from Saint Louis University and Leslie Buck, Ph.D., from the University of Toronto, have spent the last several years sequencing and analyzing the genome of the western painted turtle and the results of their research point to some important conclusions that may be important for human health. The western painted turtle, one of the most widespread and well-studied turtles, exhibits an extraordinary ability to adapt to extreme physiological conditions and it is ...

Annals of Internal Medicine tip sheet for April 23, 2013

2013-04-23
1. Benefits of Suicide Screening in Primary Care Settings Unknown The U.S. Preventive Services Task Force reviews evidence for upcoming recommendations on suicide screening and treatment for adults and adolescents An evidence review finds that there are screening tools to help physicians identify adults at risk for suicide, but there's no evidence that using these screening tools in primary care will actually prevent suicides in adults. There are still no proven primary care-relevant screening tools to identify suicide risk in adolescents. Suicide is the 10th leading ...

Mammograms reveal response to common cancer drug

2013-04-23
Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, which appears white on a mammogram, during treatment. Women who show a pronounced reduction in breast density during tamoxifen treatment have a fifty per cent reduction in breast cancer mortality. This tool provides doctors with the possibility to assess whether a patient is responding to tamoxifen at an early phase of treatment. Tamoxifen is a common ...

Bugs produce diesel on demand

2013-04-23
It sounds like science fiction but a team from the University of Exeter, with support from Shell, has developed a method to make bacteria produce diesel on demand. While the technology still faces many significant commercialisation challenges, the diesel, produced by special strains of E. coli bacteria, is almost identical to conventional diesel fuel and so does not need to be blended with petroleum products as is often required by biodiesels derived from plant oils. This also means that the diesel can be used with current supplies in existing infrastructure because engines, ...

Radioactive bacteria targets metastatic pancreatic cancer

2013-04-23
VIDEO: Claudia Gravekamp, Ph.D., discusses her research on a new therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. Dr. Gravekamp is... Click here for more information. April 22, 2013 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes ...

LAST 30 PRESS RELEASES:

AI model offers accurate and explainable insights to support autism assessment

Process for dealing with sexual misconduct by doctors requires major reform

Severe pregnancy sickness raises risk of mental health conditions by over 50%

Early humans may have walked from Türkiye to mainland Europe, new groundbreaking research suggests

New study shows biochar’s electrical properties can influence rice field methane emissions

Guangdong faces largest chikungunya outbreak on record

Tirzepatide improves blood sugar control in children aged 10-17 years with type 2 diabetes inadequately controlled on existing therapies (SURPASS-PEDS trial)

An old drug, in a low dose, shown to be safe and effective in preventing progression of type 1 diabetes in children and young people (MELD-ATG trial)

Study reports potential effects of verapamil in slowing progression of type 1 diabetes

Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at 2-year follow-up

New estimates predict over 4 million missing people who would be alive in 2025 if not for inadequate type 1 diabetes care

So what should we call this – a grue jay?

Chicago Quantum Exchange-led coalition advances to final round in NSF Engine competition

Study identifies candidates for therapeutic targets in pediatric germ cell tumors

Media alert: The global burden of CVD

Study illuminates contributing factors to blood vessel leakage

What nations around the world can learn from Ukraine

Mixing tree species does not always make forests more drought-resilient

Public confidence in U.S. health agencies slides, fueled by declines among Democrats

“Quantum squeezing” a nanoscale particle for the first time

El Niño spurs extreme daily rain events despite drier monsoons in India

Two studies explore the genomic diversity of deadly mosquito vectors

Zebra finches categorize their vocal calls by meaning

Analysis challenges conventional wisdom about partisan support for US science funding

New model can accurately predict a forest’s future

‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance

Genomic evolution of major malaria-transmitting mosquito species uncovered

Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery

Tuberculosis vulnerability of people with HIV: a viral protein implicated

Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living

[Press-News.org] Researchers identify new pathway, enhancing tamoxifen to tame aggressive breast cancer